Form 4: Progyny Director Norman Payson Reports Stock Transactions

Director Norman Payson reports acquisition of stock options and restricted stock units, along with indirect ownership details.

Summary

• Norman Payson, a director of Progyny, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 23, 2024, Payson acquired 6,176 shares of common stock underlying restricted stock units (RSUs) at $0, vesting on May 23, 2025, contingent on continued service.
• Payson also acquired options to buy 24,140 shares of common stock at an exercise price of $27.15, vesting on May 23, 2025, also contingent on continued service.
• Payson indirectly owns 281,098 shares through The Norman C. and Melinda B. Payson Revocable Trust and 122,493 shares through EVO Eagle, LLC.
• Payson disposed of 14,041 shares of common stock.

Sentiment

Score: 6

Explanation: The acquisition of RSUs and stock options is generally positive, but the disposal of some shares tempers the overall sentiment. It's a fairly neutral indicator.

Positives

• Acquisition of RSUs and stock options indicates confidence in Progyny's future performance.

Negatives

• The disposal of 14,041 shares could be interpreted negatively, although the overall holdings remain substantial.

Risks

• The vesting of RSUs and stock options is contingent on continued service, creating a potential risk if Payson were to leave the company.

Future Outlook

The vesting of RSUs and stock options in 2025 suggests a continued commitment to Progyny by Norman Payson.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can influence investor sentiment.

Comparison to Industry Standards

• Tracking insider transactions is a common practice in financial analysis, with firms like GuruFocus and InsiderScore providing tools to monitor such activities.
• Comparing Payson's transactions to those of other directors in similar healthcare companies can provide insights into the overall sentiment surrounding Progyny's stock.

Stakeholder Impact

• The transactions may influence investor sentiment regarding Progyny's stock.
• The vesting of RSUs and stock options incentivizes Payson to contribute to the company's success, benefiting shareholders.

Key Dates